Cargando…
Repurposing current therapeutic regimens against SARS-CoV-2 (Review)
The recent coronavirus outbreak has spread worldwide, with the exception of Antarctica, causing serious social and economic disruption. All disciplines of the science community are driven to confront the impact of the COVID-19 pandemic, as currently, there is neither prophylactic nor therapeutic tre...
Autores principales: | K. Konstantinidou, Sofia, P. Papanastasiou, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401312/ https://www.ncbi.nlm.nih.gov/pubmed/32782493 http://dx.doi.org/10.3892/etm.2020.8905 |
Ejemplares similares
-
Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021) -
Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2
por: Parashar, Nidarshana Chaturvedi, et al.
Publicado: (2020) -
Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
por: Santos, Jennifer, et al.
Publicado: (2020) -
Anti-HIV drug repurposing against SARS-CoV-2
por: Sang, Peng, et al.
Publicado: (2020) -
New perspective towards therapeutic regimen against SARS-CoV-2 infection
por: Srivastava, Vartika, et al.
Publicado: (2021)